Document is current
Any future updates will be listed below
-
Authors
Goeldner, Celia
Kishnani, Priya S.
Skotko, Brian G.
Casero, Julian Lirio
Hipp, Joerg F.
Derks, Michael
Hernandez, Maria-Clemencia
Khwaja, Omar
Lennon-Chrimes, Sian
Noeldeke, Jana
Pellicer, Sabine
Squassante, Lisa
Visootsak, Jeannie
Wandel, Christoph
Fontoura, Paulo
d’Ardhuy, Xavier Liogier
,
De La Torre Fornell, Rafael
Glue, Paul
Hoover-Fong, Julie
Uhlmann, Sonja
Malagón Valdez, Jorge
Marshall, Andrew
Martinón-Torres, Federico
Redondo-Collazo, Lorenzo
Rodriguez-Tenreiro, Carmen
Marquez Chin, Valeria
Michel Reynoso, Adriana G.
Mitchell, Ed A.
Slykerman, Rebecca F.
Wouldes, Trecia
Loveday, Sarah
Moldenhauer, Fernando
Novell, Ramon
Ochoa, Cesar
Rafii, Michael S.
Rebillat, Anne-Sophie
Sanlaville, Damien
Sarda, Pierre
Shankar, Rohit
Pulsifer, Margaret
Evans, Casey L.
Silva, Alexandra M.
McDonough, Mary Ellen
Stanley, Maria
McCary, Lindsay M.
Vicari, Stefano
Wilcox, William
Zampino, Giuseppe
Zuddas, Alessandro
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche
- License Information
-
More Information
Article History
Received: 10 August 2021
Accepted: 12 January 2022
First Online: 5 February 2022
Declarations
:
: This study was approved by local ethics committees and was conducted in accordance with the principles of the “Declaration of Helsinki” and Good Clinical Practice.
: Not applicable
: At the time of the study, P Fontoura, C Goeldner, MC Hernandez, JF Hipp, O Khwaja, X Liogier d’Ardhuy, J Noeldeke, S Pellicer, L Squassante, C Wandel were employees of F.Hoffmann-La Roche AG Switzerland; M Derks and S Lennon-Chrimes were employees of Roche Products Ltd. UK; J Visootsak was an employee of Roche New York. All employees (former and current) may be eligible for stock and stock options. P S Kishnani has no disclosures for Down syndrome-related research. J Lirio Casero has no disclosures. B G Skotko occasionally consults on the topic of Down syndrome through the Gerson Lehrman Group. He receives remuneration from Down syndrome non-profit organizations for speaking engagements and associated travel expenses. Dr. Skotko receives annual royalties from Woodbine House, Inc., for the publication of his book, <i>Fasten Your Seatbelt: A Crash Course on Down Syndrome for Brothers and Sisters</i>. Within the past 2 years, he has also received research funding from AC Immune and LuMind Research Down Syndrome Foundation to conduct clinical trials for people with Down syndrome. Dr. Skotko is occasionally asked to serve as an expert witness for legal cases where Down syndrome is discussed. Dr. Skotko serves in a non-paid capacity on the Honorary Board of Directors for the Massachusetts Down Syndrome Congress and the Professional Advisory Committee for the National Center for Prenatal and Postnatal Down Syndrome Resources. Dr. Skotko has a sister with Down syndrome.
